These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30328797)

  • 21. High glucose driven expression of pro-inflammatory cytokine and chemokine genes in lymphocytes: molecular mechanisms of IL-17 family gene expression.
    Kumar P; Natarajan K; Shanmugam N
    Cell Signal; 2014 Mar; 26(3):528-39. PubMed ID: 24308966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insights into IL-23 biology: From structure to function.
    Floss DM; Schröder J; Franke M; Scheller J
    Cytokine Growth Factor Rev; 2015 Oct; 26(5):569-78. PubMed ID: 26195433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-/- mice.
    Potì F; Gualtieri F; Sacchi S; Weißen-Plenz G; Varga G; Brodde M; Weber C; Simoni M; Nofer JR
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1505-12. PubMed ID: 23640484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of Interleukin-10 Producing Dendritic Cells As a Tool to Suppress Allergen-Specific T Helper 2 Responses.
    Schülke S
    Front Immunol; 2018; 9():455. PubMed ID: 29616018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-23 in the pathogenesis of rheumatoid arthritis.
    Paradowska-Gorycka A; Grzybowska-Kowalczyk A; Wojtecka-Lukasik E; Maslinski S
    Scand J Immunol; 2010 Mar; 71(3):134-45. PubMed ID: 20415779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation.
    Kikly K; Liu L; Na S; Sedgwick JD
    Curr Opin Immunol; 2006 Dec; 18(6):670-5. PubMed ID: 17010592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential expression and regulation of IL-23 and IL-12 subunits and receptors in adult mouse microglia.
    Li J; Gran B; Zhang GX; Ventura ES; Siglienti I; Rostami A; Kamoun M
    J Neurol Sci; 2003 Nov; 215(1-2):95-103. PubMed ID: 14568135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice.
    Elson CO; Cong Y; Weaver CT; Schoeb TR; McClanahan TK; Fick RB; Kastelein RA
    Gastroenterology; 2007 Jun; 132(7):2359-70. PubMed ID: 17570211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of Memory T Cells by Interleukin-23.
    Li Y; Wang H; Lu H; Hua S
    Int Arch Allergy Immunol; 2016; 169(3):157-62. PubMed ID: 27100864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin 12/interleukin 23 pathway: Biological basis and therapeutic effect in patients with Crohn's disease.
    Aggeletopoulou I; Assimakopoulos SF; Konstantakis C; Triantos C
    World J Gastroenterol; 2018 Sep; 24(36):4093-4103. PubMed ID: 30271076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-4 supports interleukin-12-induced proliferation and interferon-gamma secretion in human activated lymphoblasts and T helper type 1 cells.
    Kriegel MA; Tretter T; Blank N; Schiller M; Gabler C; Winkler S; Kalden JR; Lorenz HM
    Immunology; 2006 Sep; 119(1):43-53. PubMed ID: 16762027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel anti-inflammatory interleukin-35 as an emerging target for antiatherosclerotic therapy.
    Bobryshev YV; Sobenin IA; Orekhov AN; Chistiakov DA
    Curr Pharm Des; 2015; 21(9):1147-51. PubMed ID: 25312725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin 39: a new member of interleukin 12 family.
    Lu Z; Xu K; Wang X; Li Y; Li M
    Cent Eur J Immunol; 2020; 45(2):214-217. PubMed ID: 33456334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TLR8 and NOD signaling synergistically induce the production of IL-1β and IL-23 in monocyte-derived DCs and enhance the expression of the feedback inhibitor SOCS2.
    Schwarz H; Posselt G; Wurm P; Ulbing M; Duschl A; Horejs-Hoeck J
    Immunobiology; 2013 Apr; 218(4):533-42. PubMed ID: 22795647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-23: a key cytokine in inflammatory diseases.
    Duvallet E; Semerano L; Assier E; Falgarone G; Boissier MC
    Ann Med; 2011 Nov; 43(7):503-11. PubMed ID: 21585245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity.
    Liu Z; Yadav PK; Xu X; Su J; Chen C; Tang M; Lin H; Yu J; Qian J; Yang PC; Wang X
    J Leukoc Biol; 2011 Apr; 89(4):597-606. PubMed ID: 21227898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p38α signaling in Langerhans cells promotes the development of IL-17-producing T cells and psoriasiform skin inflammation.
    Zheng T; Zhao W; Li H; Xiao S; Hu R; Han M; Liu H; Liu Y; Otsu K; Liu X; Huang G
    Sci Signal; 2018 Mar; 11(521):. PubMed ID: 29535261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SIK inhibition in human myeloid cells modulates TLR and IL-1R signaling and induces an anti-inflammatory phenotype.
    Lombardi MS; Gilliéron C; Dietrich D; Gabay C
    J Leukoc Biol; 2016 May; 99(5):711-21. PubMed ID: 26590148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-23 in inflammatory bowel diseases and colon cancer.
    Neurath MF
    Cytokine Growth Factor Rev; 2019 Feb; 45():1-8. PubMed ID: 30563755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin 23 and autoimmune diseases: current and possible future therapies.
    Abdo AIK; Tye GJ
    Inflamm Res; 2020 May; 69(5):463-480. PubMed ID: 32215665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.